MedWatch

Pfizer gives Danish PM cold shoulder: rejects idea of starting vaccine production in Denmark

Although three of the world's largest pharmaceutical companies have expressed interest in establishing vaccine production facilities in Denmark, Pfizer is not interested in working with the Danish authorities.

Photo: Pool/Reuters/Ritzau Scanpix

Although the Pfizer/Biontech vaccine is the most widely used covid-19 vaccine in Denmark, it does not look like the companies will be establishing vaccine production facilities in the country.

That ship has sailed, as Pfizer has already expanded its production across the world, and now, it has upped its goal of producing 1.3 billion doses in 2021 to more than 2.5 billion doses. From next year onwards, more than 3 billion doses will be produced.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

Further reading

Related articles

Trial banner

Latest news

See all jobs